News Briefs

AIS Health Staff

CVS Health Corp. said on March 31 that its PBM division Caremark will “continue to serve the government-wide Service Benefit Plan” in a deal effective Jan. 1, 2022. The contract is an arrangement with carriers of the Federal Employees Health Benefits program and adds specialty drug management to Caremark’s existing contract providing retail, mail and clinical pharmacy services. Prime Therapeutics LLC previously held the specialty contract. Read more at https://bit.ly/3t11yfk.

After replacing Novartis’ psoriasis drug Cosentyx (secukinumab) with Eli Lilly and Co.’s Taltz (ixekizumab) on most of its 2021 formularies, Cigna Corp. is offering a financial incentive for recalcitrant patients to switch to the cheaper drug. In March, the insurer sent a letter advising doctors that patients could receive a $500 debit card if they switch from Cosentyx to Taltz or an older biologic before Aug. 31 and then refill the prescription before Dec. 31, according to the American Journal of Managed Care. Visit https://bit.ly/3wBh0kJ.

© 2021 MMIT

AIS Health Staff

Related Posts

https://www.mmitnetwork.com/wp-content/uploads/2021/09/Drug_Benefits_Life_Sciences.jpg
November 23

Will ‘Build Back Better’ Spell Disaster for Pharma Innovation?

READ MORE
https://www.mmitnetwork.com/wp-content/uploads/2021/11/WordPress-Featured-Image-health-plan-weekly-Wall-Street-Isnt-Sweating-Cignas-Third-Quarter-MLR-Miss.jpg
November 23

Big Three PBMs’ 3Q Results Make Up for Insurer Disappointments

READ MORE
https://www.mmitnetwork.com/wp-content/uploads/2021/11/WordPress-Featured_AdobeStock_442155384.jpg
November 23

SCAN Health Opts to Invest in Medication Adherence Tool

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today